Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Annals of Hematology|December 1, 2017
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuationAndrew T Kuykendall, Savan Shah, Chetasi Talati, et al.
Leukemia Research|May 3, 2015
Impact of tobacco usage on disease outcome in myelodysplastic syndromesAsmita Mishra, Dana E Rollison, Thomas H Brandon, et al.
Leukemia Research|April 29, 2019
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)David A Sallman, Rami S Komrokji, Kendra L Sweet, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2009
Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screeningRóbert Kiss, Tímea Polgár, Annet Kirabo, et al.
Leukemia|July 31, 2020
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)Seongseok Yun, Susan M Geyer, Rami S Komrokji, et al.
Leukemia Research|June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasiaFrancis J Giles, Alan F List, Michael Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2019
Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling NetworksSriram Sundaravel, Wen-Liang Kuo, Jong Jin Jeong, et al.
Acta Haematologica|November 22, 2014
A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institutionDeniz Peker, Eric Padron, John M Bennett, et al.
American Journal of Hematology|April 23, 2013
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromesAsmita Mishra, Maria Corrales-Yepez, Najla Al Ali, et al.
Leukemia Research Reports|June 6, 2022
Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learningDavid A Sallman, Rafael Bejar, Guillermo Montalban-Bravo, et al.
Pageof 20